Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
585.00
-10.00 (-1.68%)
At close: Mar 30, 2026
-87.00%
Market Cap 4.99B
Revenue (ttm) 389.96M
Net Income (ttm) -1.21B
Shares Out 8.54M
EPS (ttm) -876.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 22
Average Volume 25,113
Open 595.00
Previous Close 595.00
Day's Range 585.00 - 595.00
52-Week Range 360.00 - 6,200.00
Beta 0.24
RSI 32.27
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development, manufacturing, and wholesale of medical devices and medical supplies in Korea. The company offers CELLSHOT, a versatile platform for small- to medium-scale cell processing; and CellShot suite that integrates hardware, consumables, protective buffers, and digital workflows into a single non-viral cell engineering platform. It also provides SmartDrop, an free-surface analysis platform. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

Financial Performance

News

There is no news available yet.